跳至主要内容
临床试验/CTRI/2019/11/021973
CTRI/2019/11/021973尚未招募未知

Multi-centre Clinical Trial to Assess the Performance of Culture-free, End-to-end Targeted NGS (tNGS) Solutions for Diagnosis of Drug Resistant TB (DR-TB)

Foundation for Innovative New Diagnostics FIND0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. A clear TB-positive result by Xpert MTB/RIF OR Xpert MTB/RIF Ultra prior to enrolment, irrespective of RIF-resistance status,
  • 2.At risk for drug resistant TB based on at least one of the following risk factors:
  • A.Not responding TB treatment with positive sputum smear or culture after >= 3 months of standard TB treatment.
  • B.Previously diagnosed with Rif-resistant/MDR-TB and failed TB treatment with positive sputum smear or culture after >= 3months of a standard MDR-TB regiment
  • C.Previously received >1 month of treatment for a prior TB episode
  • D.Close contact with a known drug-resistant TB case
  • 3.Willing to provide sputum
  • 4.Over 18 years of age (or legal adult age corresponding to the site)
  • 5.Provision of signed informed consent

排除标准

  • 1.Have started treatment for current TB episode more than 7 days prior to date of enrolment (i.e. must have been on treatment for less than 7 days for this TB treatment episode at enrolment)
  • 2.Are pregnant or institutionalized or imprisoned

研究者

相似试验